Featured Research

from universities, journals, and other organizations

Flame retardants during pregnancy as bad as lead? Exposure linked to lower IQs in kids

Date:
May 28, 2014
Source:
Simon Fraser University
Summary:
Prenatal exposure to flame retardants can be significantly linked to lower IQs and greater hyperactivity in five-year old children. The researchers found that a 10-fold increase in PBDE concentrations in early pregnancy, when the fetal brain is developing, was associated with a 4.5 IQ decrement, which is comparable with the impact of environmental lead exposure. PBDEs have been widely used as flame retardants in furniture, carpet padding, car seats and other consumer products over the past three decades.

A new study involving Simon Fraser University researchers has found that prenatal exposure to flame retardants can be significantly linked to lower IQs and greater hyperactivity in five-year old children.
Credit: © rad100 / Fotolia

A new study involving Simon Fraser University researchers has found that prenatal exposure to flame retardants can be significantly linked to lower IQs and greater hyperactivity in five-year old children. The findings are published online today in the journal Environmental Health Perspectives.

The researchers found that a 10-fold increase in PBDE concentrations in early pregnancy, when the fetal brain is developing, was associated with a 4.5 IQ decrement, which is comparable with the impact of environmental lead exposure.

SFU health sciences professor Bruce Lanphear is part of the research team that measured the levels of flame retardants, or polybrominated diphenyl ethers, (PBDEs) in 309 U.S. women at 16 weeks of pregnancy, and followed their children to the age of five.

Researchers say their results confirm earlier studies that found PBDEs, which are routinely found in pregnant women and children, may be developmental neurotoxicants.

PBDEs have been widely used as flame retardants in furniture, carpet padding, car seats and other consumer products over the past three decades. While most items containing PBDEs were removed voluntarily from the market a decade ago, some are still in commerce and others persist in the environment and human bodies. Nearly all homes and offices still contain some PBDEs.

"The results from this and other observational human studies support efforts to reduce Penta-BDE exposures, especially for pregnant women and young children," says Lanphear. "Unfortunately, brominated flame retardants are persistent and North Americans are likely exposed to higher PBDE levels than people from other parts of the world. Because of this it is likely to take decades for the PBDE levels in our population to be reduced to current European or Asian levels."

The United Nations Environment Program (UNEP) added two of three existing commercial PBDE formulas to the list of banned Persistent Organic Pollutants (PIPs) due to concerns over toxicity in wildlife and mammals in 2009. While PBDEs were voluntarily withdrawn from the U.S. market in 2004, products manufactured before then may still contain PBDEs, which can continue to be released into the environment and accumulate via indoor dust.

The latest research highlights the need to reduce inadvertent exposure to PBDEs in the home and office environment (e.g., via dust), and in diet (e.g., via fish or meat products), to avert potential developmental neurotoxicity in pregnant women and young children.

Lanphear says additional research is needed to highlight the impact of PBDE exposure on the developing brain. He also notes that it is important to investigate related chemicals and other flame retardants used to replace PBDEs.


Story Source:

The above story is based on materials provided by Simon Fraser University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Aimin Chen, Kimberly Yolton, Stephen A. Rauch, Glenys M. Webster, Richard Hornung, Andreas Sjφdin, Kim N. Dietrich, Bruce P. Lanphear. Prenatal Polybrominated Diphenyl Ether Exposures and Neurodevelopment in U.S. Children through 5 Years of Age: The HOME Study. Environmental Health Perspectives, 2014; DOI: 10.1289/ehp.1307562

Cite This Page:

Simon Fraser University. "Flame retardants during pregnancy as bad as lead? Exposure linked to lower IQs in kids." ScienceDaily. ScienceDaily, 28 May 2014. <www.sciencedaily.com/releases/2014/05/140528105258.htm>.
Simon Fraser University. (2014, May 28). Flame retardants during pregnancy as bad as lead? Exposure linked to lower IQs in kids. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2014/05/140528105258.htm
Simon Fraser University. "Flame retardants during pregnancy as bad as lead? Exposure linked to lower IQs in kids." ScienceDaily. www.sciencedaily.com/releases/2014/05/140528105258.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) — The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) — The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) — The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) — In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins